SLUS:XETRA:XETRA-iShares MSCI USA ESG Screened UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 9.099

Change

-0.01 (-0.07)%

Market Cap

USD 0.32B

Volume

4.54K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.38 (+0.75%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.83%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.25 (+0.96%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.19 (+0.68%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.14 (+0.60%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.40 (+0.92%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.19 (+0.43%)

USD 105.55B
8R80:XETRA Amundi Index Solutions - Amund..

+0.94 (+0.66%)

USD 105.05B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.42 (+0.84%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.88 (+0.17%)

USD 80.38B

ETFs Containing SLUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.88% 81% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.88% 81% B- 78% C+
Trailing 12 Months  
Capital Gain 29.47% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.47% 87% B+ 85% B
Trailing 5 Years  
Capital Gain 92.82% 94% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 92.82% 94% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.03% 88% B+ 84% B
Dividend Return 14.03% 87% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.46% 37% F 48% F
Risk Adjusted Return 90.79% 96% N/A 96% N/A
Market Capitalization 0.32B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.